Global Arthritis Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Oct 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Arthritis Market By Rheumatoid Drug Type (Biologics, Non-Biologics, Steroids, Analgesics, Glucocorticoids, Others), Rheumatoid Diagnosis (CRP Test, CCP, ESR Test), Rheumatoid Treatment (Synovectomy, Tendon Repair, Joint Fusion, Symptomatic Treatment, Intermediate Corticosteroid Therapies, DMARD Therapies), Osteoarthritis Type (Hip, Spinal, Knee, Foot & Ankle, Shoulder, Hand), Osteoarthritis Diagnosis (Imaging, Joint Fluid Analysis, Others), Osteoarthritis Treatment (Medication, Drugs, Assistive Devices, Surgery, Therapy), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Drug Stores), End-Users (Hospitals, Clinics, Household, Medical Institutes, Research Organizations, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Arthritis Market

Global arthritis market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the increasing awareness regarding the disease and the modes of its treatment.

Market Definition: Global Arthritis Market

Arthritis, also known as inflammation of joints is described as the tenderness or swelling occurring in the joints of patients, with the symptoms of the disease being stiffness and pain in joints. It is categorized into two most common variants as rheumatoid arthritis and osteoarthritis. The patient suffers from significant lack of motion

Market Drivers

  • Rising cases of rheumatoid arthritis  worldwide will accelerate the market growth
  • Increasing aging population is another factor uplifting the market growth
  • Growing demand for minimally invasive procedures among population will also enhance the market growth
  • Increasing obesity among population also acts as market driver in the forecast period

Market Restraints

  • Increasing risk of side effects associated with treatment of arthritis will restrain the market growth
  • High cost of hyaluronic acid products will hinder the growth of the market
  • Lack of effective treatment other than symptomatic mode for osteoarthritis also acts as a market restraint

Segmentation: Global Arthritis Market

By Rheumatoid Drug Type

  • Biologics

    • TNF- α Antagonists
    • T-Cell Inhibitors
    • CD20 Antigen
    • JAK Inhibitors
    • Anti-IL6 Biologics

  • Non-Biologics

    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Synthetic Disease-Modifying Antirheumatic Drugs (SDMARDs)

  • Steroids
  • Analgesics
  • Glucocorticoids
  • Others

By Rheumatoid Diagnosis

  • C-Reactive Protein (CRP) Test
  • Cyclic Citrullinated Peptide (CCP)
  • Erythrocyte Sedimentation Rate (ESR) Test

By Rheumatoid Treatment

  • Synovectomy
  • Tendon Repair
  • Joint Fusion
  • Symptomatic Treatment
  • Intermediate Corticosteroid Therapies
  • Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapies

    • Conventional Disease-Modifying Anti-Rheumatic Drug (DMARD)
    • Biologic Disease-Modifying Anti-Rheumatic Drug (DMARD)

By Osteoarthritis Type

  • Hip
  • Spinal
  • Knee
  • Foot & Ankle
  • Shoulder
  • Hand

By Osteoarthritis Diagnosis

  • Imaging

    • X-Rays
    • Magnetic Resonance Imaging (MRI)
    • Others

  • Joint Fluid Analysis
  • Others

By Osteoarthritis Treatment

  • Medication

    • Analgesics

      • Acetaminophen
      • Duloxetine
      • Others

    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

      • Aspirin
      • Ibuprofen
      • Naproxen Sodium
      • Naproxen
      • Others

    • Others

  • Drugs

    • Food Supplements

      • Corticosteroids
      • Hyaluronic Acid Injection

        • Single Injections
        • Multiple Injections

      • Phase III Drugs
      • Others

  • Assistive Devices
  • Surgery
  • Therapy

    • Non-Pharmacological Therapy
    • Pharmacological Therapy

By Route of Administration

  • Oral
  • Parenteral

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Drug Stores

By End-Users

  • Hospitals
  • Clinics
  • Household
  • Medical Institutes
  • Research Organizations
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In October 2019, Gilead Sciences, Inc. announced that they had submitted a new drug application (NDA) for their investigational, oral, selective JAK 1 inhibitor, “filgotinib” for treatment of adults suffering from rheumatoid arthritis to the Japanese Ministry of Health, Labour and Welfare (MHLW). This application will enable the company to enhance their presence in the region for providing therapeutics for inflammation
  • In August 2019, AbbVie announced that they had received U.S. FDA approval for “RINVIQ (upadacitinib)”, once-daily 15 mg oral Janus Kinase (JAK) inhibitor designed for the treatment of adults suffering from moderate to severe range of rheumatoid arthritis having an inadequate response to methotrexate (MTX-IR). The drug will be available from late August, 2019

Competitive Analysis:

Global arthritis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of arthritis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global arthritis market are AbbVie Inc.; Pfizer Inc.; Amgen Inc.; Johnson & Johnson Services, Inc.; CELGENE CORPORATION; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd; UCB S.A.; Gilead Sciences, Inc.; Eli Lilly and Company; Novartis AG; Sanofi; AstraZeneca; Astellas Pharma Inc.; Galapagos NV; Taisho Pharmaceutical Holdings Co., Ltd.; Boehringer Ingelheim GmbH; Swedish Orphan Biovitrum AB (publ); Regeneron Pharmaceuticals; Abiogen Pharma Spa; Merck & Co., Inc.; Kolon TissueGene, Inc.; Ampio Pharmaceuticals Inc.; GlaxoSmithKline plc among others.

Research Methodology: Global Arthritis Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global arthritis market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions